NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Velico Medical

Velico Medical

Private
Beverly, MassachusettsHealthcare & Life Scienceshttps://www.veli.co/

Last Round

VC Round

Aug 1, 2024

Total Funding Raised

$39.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Velico Medical is a medical technology company developing a novel, dry plasma manufacturing system to produce point-of-care, dry plasma products for transfusion.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Biotechnology, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

spray-dried plasmadried plasmapowdered plasmashelf-stable plasmamedical devicehemorrhage controlpoint-of-care transfusiontransfusion medicineBARDABiomedical Advanced Research and Development Authoritytrauma caremilitary medicinecombat casualty careblood center equipmentemergency preparednessmedical consumablesmass casualty readiness

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Velico Medical Comparables

Compare Velico Medical with similar companies based on industry and business-model similarity.

Velico Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Teleflex Incorporated
77%
Cellphire Therapeutics
67%
Macopharma
66%

Velico Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 1, 2024
DebtMay 31, 2023
GrantAug 24, 2021
GrantSep 26, 2017

Key People

Founding team and executive leadership

Richard Meehan

Chief Executive Officer

Executive Team

Mark Barbera

Chief Financial Officer

Executive Team

Andrew Cap

Chief Medical And Scientific Officer, Chief Scientific Officer, Member Board Of Directors

Executive Team

Velico Medical Investors

Notable investors and investment history

Velico Medical investors
InvestorRounds
Public Health Emergency Medical Countermeasures EnterpriseGrant
Rosetta CapitalVC Round
New York AngelsVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 340% MoM, reaching 3.8K.

  • Nov 11, 2025

    Monthly visitors increased 33% MoM.

Velico Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Velico Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Velico Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeverly, Massachusetts
Employee Range46
Year Founded1992
Last FundingAug 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.